Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37 member A3 pseudogene (LRRC37A3 pseudogene)
- Target
- LRRC37A3 pseudogene
- Molecular classification
- Pseudogene
01
Overview
The Leucine rich repeat containing 37 member A3 pseudogene (LRRC37A3 pseudogene, ENSG00000270977) is a genomic locus in humans classified as a pseudogene, meaning it is a gene copy that has lost its protein-coding ability due to disruptive mutations. Pseudogenes generally do not encode functional proteins, though some may be transcribed and could potentially play regulatory roles at the RNA level. There is no evidence indicating functional protein expression, disease association, or relevance as a therapeutic target for this particular pseudogene[2][1][5].
- Other names
- AC015849.5
02
Mechanism of action
None; not a druggable target, mechanism of action is not applicable
03
Biological functions
None definitive; pseudogenes generally do not encode functional proteins. There is increasing evidence that some pseudogenes, when transcribed, may play regulatory roles at the RNA level, such as interacting with microRNAs or modulating expression of related genes, but no definitive function is ascribed to LRRC37A3 pseudogene specifically.
04
Disease associations
None directly established; while some pseudogenes have regulatory RNA roles in cancer and other diseases, there is no disease association reported for LRRC37A3 pseudogene.
05
Safety considerations
None reported or relevant, as it is not a therapeutic target
06
Interacting drugs
None; no drugs target this pseudogene as it does not encode a functional protein or receptor
07
Biomarkers
None established
Beyond the preview
Go deeper on Leucine rich repeat containing 37 member A3 pseudogene (LRRC37A3 pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leucine rich repeat containing 37 member A3 pseudogene (LRRC37A3 pseudogene).